.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Colorcon
Fuji
Daiichi Sankyo
McKinsey
Argus Health
Julphar
Farmers Insurance
Healthtrust
Merck

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077220

« Back to Dashboard
NDA 077220 describes PILOCARPINE HYDROCHLORIDE, which is a drug marketed by Lannett, Perrigo Pharma Intl, Impax Labs, Innogenix, and Akorn Inc, and is included in five NDAs. It is available from seven suppliers. Additional details are available on the PILOCARPINE HYDROCHLORIDE profile page.

The generic ingredient in PILOCARPINE HYDROCHLORIDE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.

Summary for 077220

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Dental and Oral Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 077220

Suppliers and Packaging for NDA: 077220

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PILOCARPINE HYDROCHLORIDE
pilocarpine hydrochloride
TABLET;ORAL 077220 ANDA KAISER FOUNDATION HOSPITALS 0179-0153 0179-0153-70 30 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (0179-0153-70)
PILOCARPINE HYDROCHLORIDE
pilocarpine hydrochloride
TABLET;ORAL 077220 ANDA Lannett Company, Inc. 0527-1313 0527-1313-01 100 TABLET, FILM COATED in 1 BOTTLE (0527-1313-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Oct 14, 2005TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:May 6, 2009TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cerilliant
Citi
Healthtrust
Daiichi Sankyo
Farmers Insurance
Moodys
Baxter
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot